The House Ways and Means Committee unanimously advanced a bill to reform Medicare Advantage prior authorization requirements.

There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost its chance to become the first one. The drug, camlipixant, was developed ...

Roger Massengale is the CEO of Eitan Group North America, developer of future-ready infusion therapy systems for hospitals, ambulatory & home settings, as well as wearable solutions for easy ...

Harshit Jain MD is the Founder and Global CEO of Doceree, the only AI-powered Operating System for healthcare marketing. A healthcare innovator, he is driving health transformation across the globe, ...